The additional funding will be used to prepare for regulatory approval and commercialization of diazepam nasal spray and pitolisant Tokyo, Japan, March 24, 2025 – Aculys Pharma, Inc. (“Aculys”), a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics in the fields of neurological and psychiatry, announced that it has […]